1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Mental health and behavioural conditions
  5. Psychosis and schizophrenia

Aripiprazole for the treatment of schizophrenia in people aged 15 to 17 years

Technology appraisal guidance [TA213] Published date: 26 January 2011

  • Guidance
  • Tools and resources
  • Information for the public
  • History
  • Overview
  • 1 Guidance
  • 2 The technology
  • 3 The manufacturer's submissions
  • 4 Consideration of the evidence
  • 5 Implementation
  • 6 Related NICE guidance
  • 7 Review of guidance
  • Appendix A: Appraisal Committee members, guideline representatives and NICE project team
  • Appendix B: Sources of evidence considered by the Committee
  • Changes after publication
  • About this guidance
  • Share
    • Share
    • Linked In
    • Twitter
    • Facebook
    • Email
    • More...
  • Download

Guidance

  • Next

6 Related NICE guidance

  • Published
  • Under development

6 Related NICE guidance

Published

  • Schizophrenia: core interventions in the treatment and management of schizophrenia in adults in primary and secondary care. NICE clinical guideline 82 (2009).

  • Guidance on the use of electroconvulsive therapy.NICE technology appraisal guidance 59 (2003).

Under development

  • Schizophrenia: the recognition and management of schizophrenia in children and young people. NICE clinical guideline.

  • National Institute for Health and Care Excellence (NICE)

  • Next